Cheng Lingyun, Toyoguchi Mitsuko, Looney David J, Lee Jeffery, Davidson Marie C, Freeman William R
Jacobs Retina Center, Department of Ophthalmology, Shiley Eye Center, University of California at San Diego, San Diego, California, USA.
Retina. 2005 Feb-Mar;25(2):193-201. doi: 10.1097/00006982-200502000-00013.
To evaluate the safety and efficiency of feline immunodeficiency virus (FIV) vectors for gene delivery into the mammalian retina.
A first-generation FIV vector was constructed and administered into rabbit eyes at two different concentrations by intravitreal or subretinal routes. A second-generation FIV vector was also constructed and administered subretinally into both rabbit and rat eyes at the same concentration. After vector administration, eyes were monitored using slit-lamp biomicroscopy, indirect ophthalmoscopy, fundus photography, and electroretinogram. After the rabbits were killed, eye tissues were processed for light microscopy and immunohistochemical analysis.
Administration of both first- and second-generation FIV vectors produced transient vitritis and/or papillitis in rabbits, without other pathologic abnormalities. Retinal pigment epithelium (RPE) cells were the predominant cell type transduced in rabbit eyes, but ganglion cells and Muller cells were also transduced. Transduction was confined to the retinal bleb area. The second-generation FIV vector transduced RPE cells much more efficiently than the first-generation vector (95% vs. 4.5%, respectively; P = 0.0015) in rabbit eyes. In contrast, no toxicity was evident over a 24- to 25-month follow-up period after injection of the second-generation FIV vector into rat eyes. Tropism in the rat eye was similar, including RPE and ganglion cells, and the RPE transduction rate was also high (50%). Transgene expression was persistent in both species over the duration of the experiment.
Second-generation FIV vectors can efficiently transfer genes into RPE cells with resulting long-term expression, properties potentially valuable to gene therapy approaches to some retinal diseases.
评估猫免疫缺陷病毒(FIV)载体向哺乳动物视网膜进行基因递送的安全性和有效性。
构建第一代FIV载体,并通过玻璃体内或视网膜下途径以两种不同浓度注入兔眼。还构建了第二代FIV载体,并以相同浓度视网膜下注射到兔眼和大鼠眼中。载体注射后,使用裂隙灯生物显微镜检查、间接检眼镜检查、眼底摄影和视网膜电图对眼睛进行监测。兔子处死后,对眼组织进行光学显微镜检查和免疫组织化学分析。
第一代和第二代FIV载体的注射均在兔眼中产生了短暂性葡萄膜炎和/或视乳头炎,未出现其他病理异常。视网膜色素上皮(RPE)细胞是兔眼中被转导的主要细胞类型,但神经节细胞和穆勒细胞也被转导。转导局限于视网膜下液泡区域。在兔眼中,第二代FIV载体转导RPE细胞的效率比第一代载体高得多(分别为95%和4.5%;P = 0.0015)。相比之下,将第二代FIV载体注入大鼠眼后,在24至25个月的随访期内未发现明显毒性。大鼠眼中的嗜性类似,包括RPE和神经节细胞,RPE转导率也很高(50%)。在实验期间,两个物种中的转基因表达均持续存在。
第二代FIV载体能够有效地将基因转移到RPE细胞中并实现长期表达,这些特性对于某些视网膜疾病的基因治疗方法可能具有潜在价值。